Response to ranibizumab therapy in neovascular AMD - an evaluation of good and bad responders. [electronic resource]
Producer: 20100524Description: 244-8 p. digitalISSN:- 1439-3999
- Aged
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Humanized
- Dose-Response Relationship, Drug
- Female
- Humans
- Macular Degeneration -- drug therapy
- Male
- Prevalence
- Prognosis
- Ranibizumab
- Retrospective Studies
- Risk Assessment
- Risk Factors
- Sex Distribution
- Switzerland -- epidemiology
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.